The United States Centers for Disease Control and Prevention (CDC) is considering authorizing the use of the common antibiotic doxicycline as a “morning-after” pill for several sexually transmitted infections, such as gonorrhea, syphilis and chlamydia. According to a recent article in The Washington Post, studies have shown the antibiotic’s effectiveness as a post-exposure prophylaxis against such infections, and the CDC is considering issuing guidelines later this summer for its use nationwide. Please click here for the full article.